PCSK1N and metabolic dysfunction-associated steatotic liver disease: Although mechanisms underlying the role of BCAAs, AAAs, and SAAs on the risk of NAFLD are unclear, some potential pathways have been proposed to explain how dietary BCAAs lead to IR, obesity, and T2D.